Head and Neck Cancers (Issue 2) | Special Reports

Treatment Update: Unresectable Medullary Thyroid Cancer

September 29, 2014

Clinical Articles

While medullary thyroid cancer (MTC) is an uncommon malignancy, accounting for about 5% of thyroid cancers, progressive forms of the disease are poorly responsive to chemotherapy and radiation.

The Side Effects of Lenvatinib

September 27, 2014

Clinical Articles

Lori J. Wirth, MD, medical director, Center for Head and Neck Cancers, Massachusetts General Hospital, assistant professor, Harvard Medical School, discusses the side effects of lenvatinib in patients with thyroid cancer.